Clario Partners With Emsere, Extends Ophthalmic Medical Imaging Capabilities
New collaboration offers end-to-end solution, supplying and training sites on ophthalmic medical imaging equipment.
Clario has announced a strategic partnership with medical equipment supplier for clinical trials, Emsere. This collaboration will provide a comprehensive, end-to-end solution that streamlines the execution of clinical trials requiring ophthalmic medical imaging and equipment.1
A key in this new partnership is Emsere’s global presence, allowing the new solution to reach sites that lack the necessary equipment to meet study protocols.
"We're thrilled to partner with Emsere in pursuit of our mutual goals. This collaboration underscores our shared commitment to providing a solution tailored to meet the diverse needs in clinical trials. Our objective is to streamline every aspect of the process. By leveraging our collective expertise, we'll deliver solutions that simplify image capture, enhance quality assessment, and optimize analysis procedures,” Joyce Suhy, PhD, executive vice president, medical imaging and specialty solutions, Clario said in a press release. “Furthermore, we're mindful of the challenges encountered by trial sites that lack the equipment to meet protocol requirements. This solution includes support and strategies to address these challenges effectively."
Earlier in March 2024, Clario announced a strategic partnership with the Cleveland Clinic’s Cole Eye Institute, bringing Cleveland Clinic’s ophthalmology imaging expertise and artificial intelligence-driven analysis platforms together with Clario’s vendor-agnostic image management system.2
The driving force behind Clario’s experience in ophthalmology is its clinical trial management platform, which enables visualization and analysis of images from all ophthalmic modalities including OCT/OCTA, color fundus photography, fluorescein angiography, and others across all major indications.
References
1. Clario partners with Emsere to extend ophthalmic medical imaging capabilities for clinical trials. News release. May 21, 2024. Accessed May 24, 2024. https://www.prnewswire.com/news-releases/clario-partners-with-emsere-to-extend-ophthalmic-medical-imaging-capabilities-for-clinical-trials-302143501.html
2. Clario and Cleveland Clinic’s Cole Eye Institute announce strategic partnership to provide new ophthalmology offerings for clinical trials. News release. March 12, 2024. Accessed May 24, 2024. https://clario.com/about/newsroom/clario-and-cleveland-clinics-cole-eye-institute-announce-strategic-partnership-to-provide-new-ophthalmology-offerings-for-clinical-trials/
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Full Phase IIIb BATURA Trial Results Show Airsupra Cuts Severe Exacerbations by 47% in Mild Asthma
May 20th 2025Results from the pivotal BATURA trial show that Airsupra (albuterol/budesonide) significantly outperformed albuterol monotherapy in reducing severe asthma exacerbations and systemic corticosteroid exposure, reinforcing its role as a next-generation, anti-inflammatory rescue therapy for mild asthma patients.
